Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.41 |
| ▸ | FABP7 | O15540 | 2/20 | 0.41 |
| ▸ | FKBP1A | P62942 | 5/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.37 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.37 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.37 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.37 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.37 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2899441 | 1.00 | POLB (0.50) | POLBFABP5FABP7FKBP1AKMT2A | |
| SCHEMBL2678864 | 0.87 | POLB (0.61) | POLBFKBP1APSEN1PSEN2APH1B | |
| SCHEMBL7433978 | 0.87 | POLB (0.61) | POLBFKBP1APSEN1PSEN2APH1B | |
| SCHEMBL23485199 | 0.87 | POLB (0.61) | POLBFKBP1APSEN1PSEN2APH1B | |
| SCHEMBL30564487 | 0.87 | POLB (0.61) | POLBFKBP1APSEN1PSEN2APH1B | |
| SCHEMBL1335555 | 0.86 | FABP5 (0.46) | POLBFABP5FABP7KMT2AEPHX2 | |
| SCHEMBL1000852 | 0.86 | FABP5 (0.46) | POLBFABP5FABP7KMT2AEPHX2 | |
| SCHEMBL4612189 | 0.86 | FABP5 (0.46) | POLBFABP5FABP7KMT2AEPHX2 | |
| SCHEMBL1336708 | 0.86 | FABP5 (0.46) | POLBFABP5FABP7KMT2AEPHX2 | |
| SCHEMBL31689008 | 0.86 | FABP5 (0.46) | POLBFABP5FABP7KMT2AEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11512096-B2 | Seco macrolide compounds | SELVITA D.O.O. (HR) | 2022-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11512096-B2 | Seco macrolide compounds | SEC61B, SEC16A, SEC61A1 | POLB 3734/4885FABP5 3549/4885FABP7 4533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.